QURE

uniQure NV Stock Price

33.065
-1.01 (-2.95%)
Upgrade to Real-Time
Regular Market
33.065

Low
28.58

52 Week Range

High
71.45

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
uniQure NV QURE NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-1.01 -2.95% 33.065 15:33:41
Open Price Low Price High Price Close Price Prev Close
34.05 32.865 34.60 34.07
Bid Price Ask Price Spread News
33.02 33.11 0.09 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,926 190,970 $ 33.39 $ 6,376,040 637,117 28.58 - 71.45
Last Trade Time Type Quantity Stock Price Currency
15:34:08 100 $ 33.065 USD

uniQure NV Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.47B 44.50M 44.28M $ 7.28M $ - -3.12 -10.40
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

uniQure NV News

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical QURE Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week33.5136.11532.5234.52283,714-0.445-1.33%
1 Month33.2936.4828.5832.75472,046-0.225-0.68%
3 Months39.5140.489928.5834.68475,081-6.45-16.31%
6 Months36.1152.1928.5838.87490,955-3.05-8.43%
1 Year55.8271.4528.5843.65490,783-22.76-40.76%
3 Years31.5082.4921.9848.63482,5791.574.97%
5 Years13.4382.494.7238.19413,17119.64146.2%

uniQure NV Description

uniQure NV is a gene therapy company. It develops treatment and platform for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers-Squibb for cardiovascular diseases.
Your Recent History
NASDAQ
QURE
uniQure NV
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210419 19:49:36